582576

Bell Pharmaceuticals, Inc — FEI 2123499

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 15, 2009
Fiscal Year
2009
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Belle Plaine, MN (United States)

Citations

IDCFRDescription
121521 CFR 211.67(b)Written procedures not established/followed
136121 CFR 211.100(a)Absence of Written Procedures
145021 CFR 211.113(a)Procedures for non-sterile drug products
180921 CFR 211.160(a)Following/documenting laboratory controls
183321 CFR 211.84(d)(1)Identity Testing of Each Component
194321 CFR 211.180(e)(1)Review of representative number of batches
358321 CFR 211.110(a)Written in-process control procedures
358521 CFR 211.110(a)Control procedures to monitor and validate performance
360321 CFR 211.160(b)Scientifically sound laboratory controls
431421 CFR 211.84(d)(2)Reports of Analysis (Components)
441221 CFR 211.194(a)(7)Signatures and dates--person who performs test